Abstract
Members of the inhibitor of apoptosis protein (IAP) family including survivin, are expressed in many tumors. However, age-related changes in their expression in cancer have not been clarified. Thus, we investigated the expression of mRNA-coding for IAP family proteins in colon cancer samples from young (<70 years of age) and elderly (>70 years) patients by real-time quantitative RT-PCR. Samples were collected from cases with well-differentiated adenocarcinoma or moderately differentiated adenocarcinoma and their adjacent normal epithelial tissue. Well-differentiated adenocarcinoma tended to express higher levels of survivin than normal mucosa, and expression in moderately differentiated adenocarcinoma was significantly greater than in normal mucosa in samples from both groups of patients (p<0.05, respectively). When samples were compared between the different age groups, the normal mucosa exhibited similar levels of survivin expression. However, samples from older patients showed a significantly higher level of expression than those from younger patients in well and moderately differentiated adenocarcinomas (p<0.05, respectively). In contrast, the levels of expression of cIAP1, cIAP2, and NAIP in the cancerous tissues were lower than those found in normal mucosa regardless of age. As for age-related changes, the expression of cIAP2 in normal mucosa and moderately differentiated adenocarcinoma was stronger in the elderly group than the young group (p<0.05, respectively), and NAIP expression in well-differentiated adenocarcinoma was higher in the young group than the elderly group (p<0.05). XIAP expression was similar in normal and cancerous tissues in both the young and elderly groups. These results suggest that the expression of IAP family proteins, especially survivin, is associated with the age-related biological characteristics of colon cancer.
Similar content being viewed by others
References
LaCasse EC, Baird S, Korneluk RG et al (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247–3259
Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315–5320
Shin S, Sung B-J, Cho Y-S et al (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117–1123
Adida C, Crotty PL, McGrath J, Berrebi D et al (1998) Developmentally regulated expression of the novel cancer anti-apoptotic gene survivin in human and mouse differentiation. Am J Pathol 152:43–49
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921
Velculescu VE, Madden S, Zhang L et al (1999) Analysis of human transcriptomes. Nature Genet 23:387–388
Kawasaki H, Toyoda M, Shinohara H et al (2001) Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91:2026–2032
Gianani R, Jarboe E, Orlicky D et al (2001) Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119–125
Okada E, Murai Y, Matsui K et al (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109–116
Rodriguez JA, Span SW, Ferreira CGM et al (2002) CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp Cell Res 275:44–53
Nakagawa Y, Yamaguchi S, Hasegawa M et al (2004) Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia. Leuk Res (in press)
Duckett CS, Nava VE, Gedrich RW et al (1996) A conserved family of cellular genes related to the baculovirus IAP gene and encoding apoptosis inhibitors. EMBO J 15:2685–2694
Liston P, Roy N, Tamai K et al (1996) Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349–353
Rothe M, Pan MG, Henzei WJ et al (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1152
Roy N, Dereraux QL, Takahashi R et al (1997) The cIAP-1 and cIAP-2 proteins are distinct inhibitors of specific caspases. EMBO J 16:6914–6925
Liston P, Fong WG, Korneluk RG (2003) The inhibitor of apoptosis: there is more to life than Bcl2. Oncogene 22:8568–8580
Tanaka K, Nagaoka S, Takemura T et al (2003) Incidence of apoptosis increases with age in colorectal cancer. Exp Gerontol 37:1469–1479
Hoffman WH, Biade S, Zilfou JT et al (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247–3257
Mirza A, McGuirk M, Hockenberry TN et al (2002) Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21:2613–2622
Kirschner M, Pujol G, Radu A (2002) Oliginucleotide microarray data mining: search for age-dependent gene expression. Biochem Biophys Res Commun 298:772–778
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113:160–168
Wang Q, Wang X, Evers BM (2003) Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. J Biol Chem 278:51091–51099
Deng Y, Lin Y, Wu X (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33–45
Tillman DM, Izeradjene K, Szucs KS et al (2003) Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res 63:5118–5125
Acknowledgements
This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 14570180).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Endo, T., Abe, S., Seidlar, H.B.K. et al. Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol Immunother 53, 770–776 (2004). https://doi.org/10.1007/s00262-004-0534-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-004-0534-8